Gilead Sciences, Inc.

Stocks

GILD

US3755581036

Real-time Estimate Cboe BZX Other stock markets 09:56:26 2026-07-10 am EDT			5-day change	1st Jan Change
132.96 ^USD	-1.39%		+2.65%	+8.40%

Jul. 08	Biopharma Companies' Second-Half Performance to be Largely Driven by Fundamentals, Morgan Stanley Says	MT
Jul. 08	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says	MT

Transcript : Gilead Sciences, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 01

Published on 06/09/2026 at 02:50 pm EDT - Modified on 06/09/2026 at 08:05 pm EDT

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Unknown Analyst (Analysts)

Good afternoon, everyone. Thank you so much for joining us. It's my pleasure to introduce the Gilead team. We have Dan O'Day, Chairman and Chief Executive

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Gilead Sciences, Inc.

Jul. 08	Biopharma Companies' Second-Half Performance to be Largely Driven by Fundamentals, Morgan Stanley Says	MT
Jul. 08	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says	MT
Jul. 08	Morgan Stanley Adjusts Price Target Gilead Sciences to $166 From $168, Maintains Overweight Rating	MT
Jul. 07	Truist Securities Adjusts Gilead Sciences Price Target to $156 From $157	MT
Jul. 07	RBC Capital Adjusts Gilead Sciences Price Target to $120 From $122, Maintains Sector Perform Rating	MT
Jul. 06	Analyst recommendations: Chubb, Delta Air Lines, Pfizer, AMD, Dow…
Jul. 06	HSBC Upgrades Gilead Sciences to Buy From Hold, Adjusts Price Target to $155 From $133	MT
Jul. 03	Trial for Ebola treatment starts in DR Congo	RE
Jul. 02	Trial for Bundibugyo Ebola treatment starts in DRC, WHO says	RE
Jun. 30	Africa CDC seeks $18 million in urgent support for Ebola drug trials in DRC	RE
Jun. 29	Gilead Sciences, Inc.(NasdaqGS:GILD) dropped from Russell 1000 Growth-Defensive Index	CI
Jun. 29	Gilead Sciences, Inc.(NasdaqGS:GILD) dropped from Russell Top 200 Growth Benchmark	CI
Jun. 29	Gilead Sciences, Inc.(NasdaqGS:GILD) dropped from Russell 3000E Growth Benchmark	CI
Jun. 28	Gilead Sciences, Inc.(NasdaqGS:GILD) dropped from Russell 3000 Growth Benchmark	CI
Jun. 28	Gilead Sciences, Inc.(NasdaqGS:GILD) dropped from Russell 1000 Dynamic Index	CI